Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel

AAPS PharmSciTech

Volumn 15, Issue 4, 2014, Pages 928-938

  Podaralla, Satheesh ^a   Alt, Carsten ^b   Shankar, Gita N ^a  

^a SRI INTERNATIONAL   (United States)

^b Palo Alto Institute for Research and Education   (United States)

Author keywords

bioadhesivity; HIV; HSV; microbicide; sexually transmitted infections; vaginal gel

Indexed keywords

MICROBICIDE; NOVEON AA 1; PLACEBO; POLOXAMER; POLYMER; UNCLASSIFIED DRUG; AGENTS USED INTRAVAGINALLY; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOADHESIVE VAGINAL GEL; CONTROLLED STUDY; DILUTION; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; GEL; MINIPIG; MOUSE; MUCOADHESION; NONHUMAN; OSMOLALITY; PH; POLYMERIZATION; PRIORITY JOURNAL; SEMINAL PLASMA; VISCOSITY; ADHESION; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG EFFECTS; MEDICINAL CHEMISTRY; OSMOLARITY; PIG; PROCEDURES; TEMPERATURE; VAGINA;

ADHESIVENESS; ANIMALS; ANTI-HIV AGENTS; CHEMISTRY, PHARMACEUTICAL; FEMALE; GELS; HYDROGEN-ION CONCENTRATION; MICE; OSMOLAR CONCENTRATION; POLYMERS; SWINE; SWINE, MINIATURE; TEMPERATURE; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VISCOSITY;

EID: 84905082751     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0124-9     Document Type: Article

References (34)

1. Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, et al. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe. 2008;4:260-70.
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 2004;11 Suppl 1:24A-35A. (Pubitemid 38529332)
3. Mantell JE, Needham SL, Smit JA, Hoffman S, Cebekhulu Q, Adams-Skinner J, et al. Gender norms in South Africa: implications for HIV and pregnancy prevention among African and Indian women students at a South African tertiary institution. Cult Health Sex. 2009;11:139-57.
4. Myer L, Kuhn L, Stein ZA, Wright Jr TC, Denny L. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis. 2005;12:786-94. (Pubitemid 41688983)
5. Global Campaign for Microbicides annual report 2005 to 2006. Available at http://www.global-campaign.org/about-microbicides.htm.
6. Abdool KQ, Salim S, Karim A, Janet AF, Anneke CG, Baxter C, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-74.
7. Shankar GN, Burke RL. Bioadhesive delivery system for transmucosal delivery of beneficial agents. U.S. Patent 2009; 7,592,021 B2.
8. Milani M, Molteni B, Silvani I. Effect on vaginal pH of a polycarbophil vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis: a randomized, controlled study. Curr Ther Res. 2000;61:781-8.
9. Alt C, Harrison T, Zukic M, Mirsalis J, D'Andrea, A. Cytokine measurements in a mouse vaginal irritation model for the safety evaluation of microbicides, presented at the 16th International Inflammation Research Association Conference, 2010, Chantilly, VA.
10. Owen DH, Katz DF. A review of the properties of human semen and formulation of a semen simulant. J Androl. 2005;26:459-69. (Pubitemid 40847857)
11. Geonnotti AR, Peters JJ, Katz DF. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen. J Pharm Sci. 2005;94:1705-12. (Pubitemid 41360865)
12. Owen DH, Peters JJ, Kieweg SL, Geonnotti AR, Schnaare RL, Katz DF. Biophysical analysis of prototype microbicide gels. J Pharm Sci. 2007;96:661-9. (Pubitemid 46466086)
13. Andrews GP, Donnelly L, Jones DS, Curran RM, Morrow RJ, Woolfson AD, et al. Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery. Biomacromolecules. 2009;10:2427-35.
14. Andrews GP, Jones DS. Rheological characterization of bioadhesive binary polymeric systems designed as platforms for drug delivery implants. Biomacromolecules. 2006;7:899-906.
15. Pillay V, Mashingaidze F, Choonara YE, Du Toit LC, Buchmann E, Maharaj V, et al. Qualitative and quantitative intravaginal targeting: Key to anti-HIV-1 microbicide delivery from test tube to in vivo success. J Pharm Sci. 2012;101:1950-68.
16. Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm. 2007;67:120-31. (Pubitemid 46991318)
17. Adriaens E, Remon JP. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis. 2008;35:512-6. (Pubitemid 351670547)
18. Lacey CJ, Woodhall S, Qi Z, Sawant S, Cowen M, McCormack S, et al. Unacceptable side effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial. Int J STD AIDS. 2010;21:714-7.
19. Owen DH, Peters JJ, Katz DF. Rheological properties of contraceptive gels. Contraception. 2000;62:321-6. (Pubitemid 32182420)
20. Chang JY, Oh YK, Choi HG, Kim YB, Kim CK. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm. 2002;241:155-63. (Pubitemid 34667075)
21. Gupta KM, Barnes SR, Tangaro RA, Roberts MC, Owen DH, Katz DF, et al. Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicide vehicles. J Pharm Sci. 2007;96:670-81. (Pubitemid 46466087)
22. Garg S, Anderson RA, Chany 2nd CJ, Waller DP, Diao XH, Vermani K, et al. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). Contraception. 2001;64:67-75. (Pubitemid 32787100)
23. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850-66.
24. Technical bulletin, number 16 (Bioadhesion), Noveon pharmaceutical polymers, January 2002.
25. Tevi-Benissan C, Belec L, Levy M, Schneider-Fauveau V, Si Mohamed A, Hallouin MC, et al. In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immunol. 1997;4:367-74. (Pubitemid 27239700)
26. Technical bulletin, number 10 (Neutralization procedure), Noveon pharmaceutical polymers, January 2002.
27. Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res. 1990;7:491-5. (Pubitemid 20322199)
28. Lard-Whiteford SL, Matecka D, O'Rear JJ, Yuen IS, Litterst C, Reichelderfer P, et al. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. J Acquir Immune Defic Syndr. 2004;36:541-52. (Pubitemid 38544502)
29. Eckstein P, Jackson MC, Millman N, Sobrero AJ. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J Reprod Fertil. 1969;20:85-93.
30. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, Ochiel DO. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol. 2010;63:544-65.
31. Veazey RS, Shattock RJ, Klasse PJ, Moore JP. Animal models for microbicide studies. Curr HIV Res. 2012;10:79-87.
32. Jacques M, Olson ME, Crichlow AM, Osborne AD, Costerton JW. The normal microflora of the female rabbit's genital tract. Can J Vet Res. 1986;50:272-4.
33. Van Damme L, Chandeying V, Ramjee G, Rees H, Sirivongrangson P, Laga M, et al. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group. AIDS. 2000;14:85-8. (Pubitemid 30072081)
34. Creatsas G, Elsheikh A, Colin P. Safety and tolerability of the new contraceptive sponge Protectaid. Eur J Contracept Reprod Health Care. 2002;2:91-5. (Pubitemid 34848344)